AZTR (Azitra) Enterprise Value-to-Revenue Coefficient

Official company branding of azitrainc.com (AZTR)

The EV/Sales trend correlates with the strong pricing power of Azitra, Inc. (AZTR) in biodermatology due to its unique modified bacteria, while the 0.00 mark reflects the latest data. The business model relies on full outsourcing of production and testing to minimize capital expenditures. Diversified express delivery channels for critical biological reagents ensure the stability of research.

Azitra Corp - AZTR EV/Sales Multiple (period 11/23/2025 - 11/19/2026)

Azitra Corporation - analytical breakdowns and key metrics (AZTR)

- market price and analyst price targets:
- business market valuation indicators:
Initial company analysis:Azitra, Inc., AZTR
Product sample of Azitra Corp

The multiple compares the total enterprise value, including debt, to sales volume, allowing for an assessment of the market value of each dollar of revenue regardless of financial leverage. For Azitra, Inc. (AZTR), which focuses on R&D in dermatological proteins, the EV-to-revenue trend reflects market expectations for the commercialization of innovations, where deviations from average values signal a reassessment of the potential for microbiome solutions.